Targeted disruption of the inosine 5′-monophosphate dehydrogenase type I gene in mice

被引:58
作者
Gu, JJ
Tolin, AK
Jain, J
Huang, H
Santiago, L
Mitchell, BS
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[5] Vertex Pharmaceut Inc, Cell Biol & Immunol, Cambridge, MA USA
关键词
D O I
10.1128/MCB.23.18.6702-6712.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inosine 5'-monophosphate dehydrogenase (IMPDH) is the critical, rate-limiting enzyme in the de novo biosynthesis pathway for guanine nucleotides. Two separate isoenzymes, designated IMPDH types I and II, contribute to IMPDH activity. An additional pathway salvages guanine through the activity of hypoxanthine-guanine phosphoribosyltransferase (HPRT) to supply the cell with guanine nucleotides. In order to better understand the relative contributions of IMPDH types I and II and HPRT to normal biological function, a mouse deficient in IMPDH type I was generated by standard gene-targeting techniques and bred to mice deficient in HPRT or heterozygous for IMPDH type II. T-cell activation in response to anti-CD3 plus anti-CD28 antibodies was significantly impaired in both single- and double-knockout mice, whereas a more general inhibition of proliferation in response to other T- and B-cell mitogens was observed only in mice deficient in both enzymes. In addition, IMPDH type I-/- HPRT-/0 splenocytes showed reduced interleukin-4 production and impaired cytolytic activity after antibody activation, indicating an important role for guanine salvage in supplementing the de novo synthesis of guanine nucleotides. We conclude that both IMPDH and HPRT activities contribute to normal T-lymphocyte activation and function.
引用
收藏
页码:6702 / 6712
页数:11
相关论文
共 37 条
  • [1] CARR SF, 1993, J BIOL CHEM, V268, P27286
  • [2] CARRERA AC, 1994, J BIOL CHEM, V269, P19435
  • [3] COLLART FR, 1992, CANCER RES, V52, P5826
  • [4] COLLART FR, 1988, J BIOL CHEM, V263, P15769
  • [5] DAYTON JS, 1994, J IMMUNOL, V152, P984
  • [6] DAYTON JS, 1992, MOL PHARMACOL, V41, P671
  • [7] LYMPHOCYTE-SELECTIVE CYTOSTATIC AND IMMUNOSUPPRESSIVE EFFECTS OF MYCOPHENOLIC-ACID INVITRO - ROLE OF DEOXYGUANOSINE NUCLEOTIDE DEPLETION
    EUGUI, EM
    ALMQUIST, SJ
    MULLER, CD
    ALLISON, AC
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 33 (02) : 161 - 173
  • [8] A mutational analysis of the active site of human type II inosine 5′-monophosphate dehydrogenase
    Futer, O
    Sintchak, MD
    Caron, PR
    Nimmesgern, E
    DeCenzo, MT
    Livingston, DJ
    Raybuck, SA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2002, 1594 (01): : 27 - 39
  • [9] REGULATION OF IMP DEHYDROGENASE GENE-EXPRESSION BY ITS END-PRODUCTS, GUANINE-NUCLEOTIDES
    GLESNE, DA
    COLLART, FR
    HUBERMAN, E
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (11) : 5417 - 5425
  • [10] Regulation of the human inosine monophosphate dehydrogenase type I gene - Utilization of alternative promoters
    Gu, JJ
    Spychala, J
    Mitchell, BS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) : 4458 - 4466